Hydroxychloroquine-induced erythema multiforme

被引:6
作者
Koumaki, Dimitra [1 ]
Koumaki, Vasiliki [2 ]
Bertsias, George [3 ]
Boumpoucheropoulos, Sotirios [4 ]
Katoulis, Alexander [5 ]
Stefanidou, Maria [1 ]
Miaris, Orestis [6 ]
Evangelou, George [1 ]
Zografaki, Kyriaki [1 ]
Krueger-Krasagakis, Sabine Elke [1 ]
Krasagakis, Konstantinos [1 ]
机构
[1] Univ Hosp Heraklion, Dermatol Dept, Iraklion 71110, Greece
[2] Med Sch Athens, Microbiol Dept, Athens, Greece
[3] Univ Hosp Heraklion, Rheumatol Dept, Iraklion, Greece
[4] Gen Oncol Hosp, Dept Med Oncol, Athens, Greece
[5] Natl & Kapodistrian Univ Athens, Attikon Gen Univ Hosp, Dept Dermatol & Venereol 2, Med Sch, Athens, Greece
[6] Med Sch Crete, Iraklion, Greece
来源
CLINICAL CASE REPORTS | 2020年 / 8卷 / 03期
关键词
antimalarials; erythema multiforme; hydroxychloroquine; severe cutaneous adverse drug reactions;
D O I
10.1002/ccr3.2648
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Hydroxychloroquine is a commonly used medication and rarely may result in development of erythema multiforme. This potential cutaneous side effect should be highlighted in information given to patients prior to hydroxychloroquine commencement.
引用
收藏
页码:578 / 579
页数:2
相关论文
共 2 条
  • [1] Hydroxychloroquine-Induced Erythema Multiforme
    Abou Assalie, Nour
    Durcan, Robert
    Durcan, Laura
    Petri, Michelle A.
    [J]. JCR-JOURNAL OF CLINICAL RHEUMATOLOGY, 2017, 23 (02) : 127 - 128
  • [2] Shipman WD, 2019, J AM ACAD DERMATOL, VS0190-9622, P32387